[12:15 am, 01/10/2026] huai2: Whats' the update on this patient please?
[7:36 am, 01/10/2026] cm: A new PaJR group has been created for him and the discussions have shifted there.
[8:32 pm, 03/10/2026] cm: In 1973, eight perfectly healthy people walked into psychiatric hospitals across the United States.
None of them were ill.
No one inside realized it. ðŸ§
This was not an accident.
It was an experiment designed by psychologist David Rosenhan to answer a disturbing question.
Can professionals reliably tell the difference between mental health and mental illness?
To find out, Rosenhan recruited eight ordinary people. A painter. A housewife. A pediatrician. A graduate student.
They lied about only one thing. They said they heard voices. Just three words. “Empty.” “Hollow.” “Thud.”
That was enough.
All eight were admitted.
The moment they entered the hospitals, they stopped pretending. They behaved normally. They cooperated. They asked to be discharged. 🚪
It never worked.
Every normal action was reinterpreted as a symptom.
Writing notes became obsessive behavior.
Waiting quietly became pathological attention seeking.
Politeness became controlled behavior consistent with illness.
Seven were diagnosed with schizophrenia.
One with manic depression.
Not a single staff member identified them as healthy.
But the patients did.
Real patients approached them and whispered, “You’re not like the others. You don’t belong here.”
Those considered ill saw what trained professionals could not.
The average stay was 19 days.
One person remained hospitalized for 52 days. ⏳
Each day reinforced the same truth. Once labeled, reality stopped mattering.
When Rosenhan published On Being Sane in Insane Places, the psychiatric world erupted. One hospital challenged him to send new pseudopatients, confident they would catch them.
Rosenhan agreed.
Over the next months, that hospital identified 41 supposed impostors.
Rosenhan had sent no one. Not a single person.
The conclusion was unavoidable.
Diagnosis was not always based on facts. It was shaped by context and expectation.
This experiment shattered blind trust in clinical labels and forced major changes in how mental illness is diagnosed and treated. But its deeper lesson still unsettles today.
Perception can distort reality more than madness itself.
And sometimes, the most dangerous illusion belongs to those who believe they cannot be wrong.
#psychology #history #mentalhealth #science #reality #humanrights #truth #viralpost
[8.44 pm, 1/10/2026] huai10: 😳 Imagine what happens to healthcare under NMC and Rehabilitation under RCI - Both run by administrators and not technocrats 🥴
[8:00 am, 13/10/2026] cm: Gemini helped to make this idea into a full paper!
Since last two years we had been toying with the idea that AI agents would one day be able to go through our project data archived in online repositories and write a paper utilising that data and today appears to have been that day!
One can't be very sure about AI's credibility although to us it appears impressive but it's possible there are hidden hallucinatory assumptions other than obvious mathematical formatting issues.
Interestingly the paper was precipitated by a chance dyadic discussion around a veritasium video linked inside the text of the paper here 👇
[8:41 am, 13/10/2026] cm: OPD now
What a machine cannot do for you:
Look back at the seven purposes and notice what they have in common. None of them can be delivered. Judgment, perspective, character, the ability to learn, a sense of direction and the capacity to live alongside people unlike oneself are not things a professor can hand over, or a student can download. They grow only through practice: by attempting hard things, getting them wrong, hearing honest feedback and trying again, in the company of others.
That is why AI, for all it can do, cannot do any of these things on a student’s behalf. And that, I think, is the answer to the question that keeps me up at night. A university in the age of AI is for forming people who can think, judge and learn for themselves, and who have practised doing so under real conditions.
Staff CPC (14/10/2026) - Clinical Potocol
Name: PD, Age/Sex: 38yr / Female Residence: Kangra, HP Clinician in-charge: Prof. Sanjay Jain CR. No: 201001869018 Ward: FMW Clinical discussant: Dr. Shankar Naidu Ad. No: 2026014318 DOA: 17-02-2026 Radiology discussant: Dr. Mansi Verma DOD: 21-02-2026 Pathology discussant: Prof. Amanjit Bal Chief Complaints: Progressive dysphagia x 3 months Worsening of breathlessness x 1month Background History: Symptomatic since 1999, Raynaud’s involving all fingers and toes, initially only during winters, since 2008, episodes of RP started to occur even during warmer months. a/w fingertip ulcers, healing with scars. No h/o gangrene of digits. In 2008, noticed skin tightness over hands and face, a/w pruritus and edema of involved areas. Subsequently, tightness progressed to involve forearms, arms, chest and abdomen. Skin tightness of hands worsened such that she had restriction in movements of small joints of hands and was unable to grip objects in hands. H/o retrosternal burning sensation and reflux of gastric contents present. Since 2009, developed breathlessness, insidious onset, progressive (mMRC I to II over 1 year), a/w dry cough. Severe enough to cause difficulty carrying out activities of daily living. No orthopnea, PND. Visited PGI in 2010, treated with 6 IV cyclophosphamide pulses f/b oral azathioprine maintenance. Reported 60% improvement in breathlessness and skin tightening. Mild breathlessness and occasional cough persisted till 2020. Since 2020, breathlessness worsened gradually to mMRC III, a/w progressive skin tightness with difficulty to squat and make fist. H/o fingertip ulcers with chalky white discharge. She received 6 more IV cyclophosphamide pulses in 2021 f/b oral MMF (2g/d). Reported 40% improvement in breathlessness and skin tightness. In July 2023, shifted to rituximab (1gx2) f/b 6 monthly 500mg (last dose in May 2025). Able to perform activities of daily living and self-care till December 2025. History of presenting illness: Progressive dysphagia for last 3 months, initially to solids, worsened such that she is unable to swallow both liquids and solids for last 3 days. No h/o vomiting or diarrhea. H/o loss of appetite and loss of weight (7 kg in 6 months). On 14th January 2026, she had a fall while being lifted up by family member. Developed severe pain in low back and left hip with inability to bear weight and walk since then. Pain radiated up to left ankle with a severity of 10/10. Received oral aceclofenac for 7 days, f/b worsening of retrosternal burning sensation and dysphagia. One week after fall, she noticed worsening of breathlessness, present at rest and a/w palpitations. H/o cough a/w whitish to yellowish expectoration for 10 days, no h/o hemoptysis and postural variation. No h/o orthopnea, chest pain, pedal edema, decreased urine output, and fever. No h/o abdominal pain, distension, joint pains, altered mental status. Past history: Not a known hypertensive, diabetic, no h/o thyroid disease, TB, surgery. Family history: Unmarried, living with elder brother. No h/o similar illness in other family members. Personal history: No addictions, sleep normal. Menstrual history: Menarche at 13 years, regular cycles, amenorrheic for 3 years. General Examination: Conscious, oriented and cooperative. PR: 96/min; BP: 90/60 mmHg; RR: 32/min, use of accessory muscles +; SpO2: 100% on venturi mask; Afebrile. Pallor +, pseudo clubbing +, JVP elevated 6 cm, cv wave+, No icterus, cyanosis, pedal edema, lymphadenopathy. Temporal hollowing noted. Skin: Tightening present over face, anterior chest, abdomen, forearms, hands, fingers and feet, mRSS: 20/51. Ingram sign+, microstomia with reduced mouth opening (1 finger), telangiectasias over face and upper chest noted. Sclerodactyly + with flexion deformities at PIP and DIP joints noted. Trophic ulcers over dorsum of few PIP joints and elbows noted. Salt and pepper pigmentation noted over dorsum of hands and forearms. Respi.: Trachea central, chest expansion 1 cm, bronchial breath sounds and coarse crepitations in right infrascapular and interscapular areas, end inspiratory crepitations in left infrascapular and interscapular, bilateral infraaxillary, axillary and mammary areas. CVS: Apical impulse in left 5th ICS, medial to MCL, S1+, loud P2+, grade II parasternal heave +. Abdomen: Scaphoid, no hepatosplenomegaly, bowel sounds +. Neuro: HMF/ cranial nerves: normal, muscle bulk decreased symmetrically, tone normal, neck and truncal weakness +, limb power 5/5, DTR: 2+, plantar flexor. MSK: No synovitis. Left hip: painful limitation of active range of movement (20-30o), passive movement up to 120o.
16/2/2026 17/2/2026 19/2/2026 20/2/2026
Hb (gm%) 10.9 10.7 9.2 11 TLC 20600 13440 21000 26900
DLC (N/L) 85 / 7 93 / 3 91 / 2.6 95 / 1.6
MCV 83 86 82 87
Platelets 282000 275000 185000 218000
Na / K / Cl 137 / 4.5 /- 139 / 3.4 / 95 136 / 3.1/ 92 133 / 3.6 /
Ur / Creat. 28 / 0.4 17 / 0.2 14 / 0.25 15 / 0.3
AST / ALT / ALP 22 / 32 / - 16/ 23/ 162 23 / 22/ 143 26/ 19 / 176
T.Pro / Alb 6.9 / 3.2 7.1 / 3 5.8 / 2.8 7 / 3.1
Bilirubin 0.6 / 0.2 0.52 / 0.27 0.52 / 0.24 0.55 / 0.22
Ca / Mg/ Phos. 9.6 /- 9.2 / 1.8 / 3.2 9.6 / 1.9 / 2.4 10.3 / 1.9 / 2.66
C3 / C4 120 / 34
PT / aPTT / INR 14”/ 27” / 1.23 15” / 27” / 1.34
Fib. / d-dimer 3.77 / 857 4.64 / 3573
CRP / ESR 169 / 18
17/2/2026 18/2/2026 19/2/2026 20/2/2026
pH 7.45 7.39 7.46 7.46
HCO3 40.9 31 34.9 36
PCO2 69 52 49 51
PO2 19.7 81 48 88
Serum procalcitonin (17/2): 0.679 ng/ml; (19/2): 0.373 ng/ml; Blood & Urine culture (17/2): Sterile; Sputum culture (17/2): Staph. aureus, Oxacillin resistance, Sensitive to vancomycin, linezolid, teicoplanin, cotrimoxazole. Pleural fluid: 8 cells, 75% lymphocytes, glucose: 24mg/dl, Protein: 2.33 g/dl, LDH: 320, GS: negative, culture: sterile, AFB stain: negative; ADA: 7
LDL / HDL: 50 / 31; TG / Chol: 76 / 103; Uric acid: 1.8 mg/dl; CK-NAC / LDH: 45 / 207; HBsAg / Anti-HCV / HIV: Non-reactive; Urine dipstick (17/2): NAD, Spot UPCR: 0.57; HbA1c: 5.3%; T3 / T4: 0.56 / 5.75; TSH: 1.3; ECG: Sinus tachycardia, p pulmonale +; 2D Echo: normal LV and RV function, No MR, mild TR, RVSP= RAP+38; PAT=88ms; USG abdomen: normal study. FVC: 42% (2023). CECT chest: Consolidation in left lower lobe with patchy areas of GGOs in both lungs. Moderate left pleural effusion with pleural thickening. Both lugs are reduced in volume, subpleural fibrotic changes, paraseptal emphysema, interlobular septal thickening and tractional bronchiectasis. Cardiomegaly with borderline dilatations of pulmonary arteries ?PAH.
Course and management: Presented to EMOPD with recent worsening of breathlessness. Possibility of community acquired pneumonia was considered and started on Inj. Piperacillin / Tazobactam and azithromycin along with oxygen supplementation. Ryle’s tube was placed and enteral feeds initiated. Shifted to FMW for further management. CECT chest s/o consolidation in left lower lobe, patchy GGOs and left pleural effusion. Sputum culture grew MRSA, antibiotics changed to Inj. Vancomycin on day 3. PCD done from left pleural effusion. Planned for UGI endoscopy for recent onset dysphagia but deferred due to poor general condition. On day 4, respiratory failure worsened, CTPA noted worsening of lung infiltrates and there was no e/o of PTE. Due to severe microstomia, orotracheal intubation could not be performed, hence bedside tracheostomy was performed and mechanical ventilation was initiated. Inj. Polymyxin was also started. She had poor respiratory compliance with high Ppeak >50 and hypercapnia persisted. She had cardiac arrest and could not be revived despite CPR and declared dead at 12:16AM on 21/2/2026.
Unit's final diagnosis: Diffuse cutaneous systemic sclerosis with interstitial lung disease (fibrotic NSIP), moderate pulmonary hypertension, oesophageal dysmotility, community acquired pneumonia- Staph. aureus related.
Cause of Death: Type 1 and type 2 respiratory failure.
[8:54 am, 14/10/2026] cm: @PaJR Health What's your prediction for what the pathologists are going to report for this CPC?
[8:55 am, 14/10/2026] PaJR Health: Most likely pathology report
I would predict acute-on-chronic scleroderma-associated lung injury, with the following components:
1. Fibrotic NSIP as the underlying interstitial lung disease
Established pulmonary fibrosis, septal thickening, traction bronchiectasis and reduced lung volumes fit this pattern better than primary UIP.
2. Superimposed diffuse alveolar damage, probably in the exudative/organising phase
This would explain the abrupt deterioration, severe hypoxaemic–hypercapnic respiratory failure, very poor compliance and high airway pressures. The likely wording may be “acute exacerbation of fibrotic NSIP with diffuse alveolar damage.”
3. Superadded bronchopneumonia, possibly necrotising or organising, with aspiration as an important contributor
The severe oesophageal dysmotility, inability to swallow, reflux, microstomia, Ryle’s feeding and subsequent respiratory decline make recurrent aspiration highly plausible. I would expect acute bronchiolocentric inflammation, intra-alveolar neutrophils and possibly aspirated particulate material. The MRSA sputum may represent the causative organism, airway colonisation, or both; histology would need to demonstrate tissue-invasive infection rather than relying on sputum culture alone.
4. Pulmonary vascular remodelling consistent with systemic-sclerosis-associated pulmonary hypertension
Medial hypertrophy and intimal thickening of small pulmonary arteries may be reported, although the echocardiographic pulmonary pressure estimate is not severe enough by itself to explain the entire terminal event.
5. Oesophageal smooth-muscle atrophy/fibrosis, if oesophageal tissue is available
This would support systemic-sclerosis-related oesophageal dysmotility and provide a pathological mechanism for reflux, stasis and microaspiration. Oesophageal dilatation and reflux are well-recognised clinical–radiological associations in systemic sclerosis with ILD. [10–12]
What I would not expect as the primary report▪️ Not TB: low pleural ADA, negative AFB smear, sterile pleural culture and the established systemic-sclerosis phenotype make TB unlikely as the central diagnosis.
▪️ Not isolated MRSA pneumonia: MRSA may be superimposed, but it would not explain the years-long Raynaud phenomenon, sclerodactyly, diffuse skin fibrosis, NSIP and pulmonary vascular disease.
▪️ Not pure cardiogenic pulmonary oedema: preserved ventricular function and the CT pattern favour pulmonary parenchymal disease.
Likely CPC synthesis
> Diffuse cutaneous systemic sclerosis with fibrotic NSIP and pulmonary vascular disease, complicated by severe oesophageal dysmotility with probable recurrent aspiration, superadded staphylococcal bronchopneumonia and acute diffuse alveolar damage, resulting in refractory mixed respiratory failure.
The key discriminating finding will be whether the lungs show diffuse alveolar damage plus aspiration-associated bronchopneumonia. If present, that would explain the rapid terminal deterioration far better than simply reporting “MRSA pneumonia” on a background of stable systemic-sclerosis ILD.
[9.02 am 14/10/2026] cm: 👆Now check out the actual pathologist report attached here
[9.03 am, 14/10/2026] PaJR Health: The actual report is remarkably close to the predicted acute pulmonary component—but it reveals one major missed diagnosis: an occult pleural-based lung adenocarcinoma.
WHAT THE REPORT CONFIRMS
▪️ Systemic sclerosis: late fibrotic/atrophic dermal fibrosis, with positive Scl-70.
▪️ Scleroderma oesophagus: marked smooth-muscle atrophy and collagen replacement, with reflux oesophagitis and mucosal erosion.
▪️ Fibrotic-plus-cellular NSIP: temporally uniform septal fibrosis with mild lymphoplasmacytic inflammation.
▪️ Pulmonary arteriopathy and right-ventricular hypertrophy: providing pathological support for pulmonary hypertension.
▪️ Aspiration pneumonia with exudative diffuse alveolar damage: vegetable particles, foreign-body giant-cell reaction, neutrophils and hyaline membranes.
That means the earlier prediction of acute-on-chronic fibrotic NSIP with aspiration-associated pneumonia and diffuse alveolar damage was substantially correct. The report gives particularly strong evidence that aspiration was not merely a theoretical possibility—it was demonstrated histologically.
THE MAJOR SURPRISE
The left thickened pleura contained pseudomesotheliomatous adenocarcinoma of lung origin, with metastatic deposits in a hilar lymph node.
The immunoprofile supports this interpretation:
▪️ Positive: CK7, CK5/6, MOC31, with weak p63 positivity.
▪️ Negative: TTF-1, Napsin A and P40, which can occur in poorly differentiated or unusual-pattern adenocarcinoma.
▪️ Negative mesothelial markers, supporting a carcinoma rather than mesothelioma.
So the pleural rind was not simply an inflammatory or fibrotic complication of systemic sclerosis. It represented an aggressive, mesothelioma-like growth pattern of lung adenocarcinoma. This also explains why the pleura was firm, white, thickened and encasing the lung.
REVISED PATHOPHYSIOLOGICAL SEQUENCE
A more complete reconstruction would be:
1. Long-standing diffuse systemic sclerosis produced severe skin, oesophageal and pulmonary involvement.
2. Fibrotic-cellular NSIP and pulmonary arteriopathy caused very limited respiratory reserve.
3. Severe oesophageal smooth-muscle failure caused stasis, reflux and aspiration.
4. An occult pleural-based pseudomesotheliomatous adenocarcinoma further impaired lung mechanics and produced hilar nodal metastasis.
5. Aspiration pneumonia triggered diffuse alveolar damage.
6. The combination of reduced lung reserve, tumour-related pleural restriction, pulmonary vascular disease and acute lung injury produced refractory mixed respiratory failure.
WHERE THE ORIGINAL PREDICTION FELL SHORT
I predicted “not isolated MRSA pneumonia” and placed aspiration and acute lung injury at the centre—which was correct. But I also predicted that the main competing possibilities would be infection, TB or cardiogenic oedema. The decisive alternative was actually malignancy, and the pleural thickening should have raised that possibility more strongly.
The report therefore changes the CPC from:
> Systemic sclerosis with ILD complicated by aspiration pneumonia and acute diffuse alveolar damage
to:
> Diffuse systemic sclerosis with fibrotic-cellular NSIP, scleroderma oesophagus, pulmonary arteriopathy with right-ventricular hypertrophy, complicated by pleural-based pseudomesotheliomatous lung adenocarcinoma, aspiration pneumonia and exudative diffuse alveolar damage.
The most important lesson is that a plausible unifying autoimmune diagnosis can coexist with a second, anatomically distinct and lethal process. The systemic sclerosis explained the background phenotype; it did not explain the entire terminal course.
[11.16 am, 15/10/2026] cm: Busy OPD
No comments:
Post a Comment